|
Volumn 10, Issue 6, 2006, Pages 723-725
|
Using evidence-based practice to reduce central line infections.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLORHEXIDINE;
CHLORHEXIDINE GLUCONATE;
DRUG DERIVATIVE;
TOPICAL ANTIINFECTIVE AGENT;
CAUSE OF DEATH;
CENTRAL VENOUS CATHETERIZATION;
CLINICAL PROTOCOL;
COST OF ILLNESS;
CROSS INFECTION;
ECONOMICS;
EQUIPMENT;
EVIDENCE BASED MEDICINE;
HUMAN;
INFECTION CONTROL;
INTRADERMAL DRUG ADMINISTRATION;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
PRACTICE GUIDELINE;
PUBLIC HOSPITAL;
REVIEW;
RISK FACTOR;
SAFETY;
SKIN CARE;
STANDARD;
TOTAL QUALITY MANAGEMENT;
UNITED STATES;
ADMINISTRATION, CUTANEOUS;
ANTI-INFECTIVE AGENTS, LOCAL;
CATHETERIZATION, CENTRAL VENOUS;
CAUSE OF DEATH;
CHLORHEXIDINE;
CLINICAL PROTOCOLS;
COST OF ILLNESS;
CROSS INFECTION;
EQUIPMENT CONTAMINATION;
EVIDENCE-BASED MEDICINE;
HOSPITALS, VETERANS;
HUMANS;
INFECTION CONTROL;
OHIO;
PRACTICE GUIDELINES;
RISK FACTORS;
SAFETY MANAGEMENT;
SKIN CARE;
TOTAL QUALITY MANAGEMENT;
UNIVERSAL PRECAUTIONS;
MLCS;
MLOWN;
|
EID: 39049190676
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/06.cjon.723-725 Document Type: Review |
Times cited : (8)
|
References (11)
|